Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions

被引:98
|
作者
Lichtenberg, Artur
Tudorache, Igor
Cebotari, Serghei
Suprunov, Mark
Tudorache, Greta
Goerler, Heidi
Park, Joon-Keun
Hilfiker-Kleiner, Denise
Ringes-Lichtenberg, Stefanie
Karck, Matthias
Brandes, Gudrun
Hilfiker, Andres
Haverich, Axel
机构
[1] Hannover Med Sch, Div Thorac & Cardiovasc Surg, Dept Thorac & Cardiovasc Surg, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Nephrol Cardiol & Angiol, D-30625 Hannover, Germany
[3] Hannover Med Sch, Lab Cell Biol & Electron Microscopy, D-30625 Hannover, Germany
关键词
tissue engineering; surgery; valves;
D O I
10.1161/CIRCULATIONAHA.105.001206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The in vivo regeneration capacity of decellularized heart valve grafts is still controversial. The aim of this study was to evaluate function, morphological changes, and cellular composition of decellularized versus re-endothelialized ovine pulmonary valves (PV) after implantation into lambs for 1 or 3 months. Methods and Results - PV (n = 21) were decellularized using detergents. Twelve PV were repopulated with autologous jugular veins endothelial cells (ECs) in a dynamic pulsatile bioreactor under simulated physiological conditions. Morphological evaluation before implantation included histological stainings (H& E, Movat-pentachrome, von-Kossa, DAPI), immunostainings (anti-perlecan, anti-eNOS, anti-procollagen-I, anti-SM-alpha-actin), electron microscopy (EM), and DNA extraction. Decellularization led to cell- free scaffolds with preserved extracellular matrix (ECM) including basement membrane. Reseeded PV (n = 5) were completely covered with ECs expressing endothelial nitric oxide synthase (eNOS) and von Willebrand factor (vWF). The function of orthotopically implanted decellularized and re-endothelialized PV (n = 7, each) was analyzed after 1 and 3 months by echocardiography and revealed no differences in competence between both groups. A confluent EC monolayer expressing eNOS/ vWF was only found in re-endothelialized PV but not in decellularized PV, whereas the valve matrices were comparable repopulated with interstitial cells expressing SM-alpha-actin and procollagen-I. More thrombotic and neointima formations were observed in decellularized PV. No signs of calcification were detected in both PV types. Conclusion - In vitro re-endothelialization of detergent-decellularized valves with autologous ECs under simulated physiological conditions significantly improves total EC valve coverage 3 months after implantation, whereas the valve repopulation with interstitial cells in vivo occurs most likely by cell migration inside the scaffold.
引用
收藏
页码:I559 / I565
页数:7
相关论文
共 50 条
  • [1] Preclinical testing of tissue engineered heart valves re-endothelialized under simulated physiological conditions
    Lichtenberg, A
    Tudorache, I
    Cebotari, S
    Sturz, G
    Goerler, H
    Ringes-Lichtenberg, S
    Karck, M
    Brandes, G
    Hilfiker, A
    Haverich, A
    [J]. CIRCULATION, 2005, 112 (17) : U814 - U814
  • [2] Porcine Umbilical Cord Perivascular Cells for Preclinical Testing of Tissue-Engineered Heart Valves
    Latifi, Neda
    Lecce, Monica
    Simmons, Craig A.
    [J]. TISSUE ENGINEERING PART C-METHODS, 2021, 27 (01) : 35 - 46
  • [3] Preclinical Testing of Living Tissue-Engineered Heart Valves for Pediatric Patients, Challenges and Opportunities
    Movileanu, Ionela
    Harpa, Marius
    Al Hussein, Hussam
    Harceaga, Lucian
    Chertes, Alexandru
    Al Hussein, Hamida
    Lutter, Georg
    Puehler, Thomas
    Preda, Terezia
    Sircuta, Carmen
    Cotoi, Ovidiu
    Nistor, Dan
    Man, Adrian
    Cordos, Bogdan
    Deac, Radu
    Suciu, Horatiu
    Brinzaniuc, Klara
    Casco, Megan
    Sierad, Leslie
    Bruce, Margarita
    Simionescu, Dan
    Simionescu, Agneta
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [4] Tissue-Engineered Heart Valves
    Filova, E.
    Straka, F.
    Mirejovsky, T.
    Masin, J.
    Bacakova, L.
    [J]. PHYSIOLOGICAL RESEARCH, 2009, 58 : S141 - S158
  • [5] De-Endothelialized Aortic Homografts: A Promising Scaffold Material for Tissue-Engineered Heart Valves
    Jing, Hui
    Wang, Zhenzhen
    Chang, Qing
    [J]. CELLS TISSUES ORGANS, 2014, 200 (3-4) : 195 - 203
  • [6] A Disposable Bioreactor for Culturing and Testing of Tissue-engineered Heart Valves
    Neerincx, P. E.
    Meijer, H. E. H.
    [J]. INTERNATIONAL POLYMER PROCESSING, 2010, 25 (02) : 149 - 158
  • [7] TISSUE-ENGINEERED HEART VALVES WITH THE AUTOASSEMBLY METHOD
    Lepage, M-A.
    Ruel, J.
    Fradette, J.
    Laroche, G.
    Perron, J.
    Germain, L.
    Auger, F-A.
    [J]. CARDIOLOGY, 2017, 137 : 298 - 298
  • [8] Tissue-engineered heart valves: Bioreactor - yes or no?
    Dainese, Luca
    Barili, Fabio
    Biglioli, Paolo
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (05): : 1189 - 1190
  • [9] Progress Toward Tissue-Engineered Heart Valves
    Mack, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (13) : 1330 - 1331
  • [10] Flow-dependent re-endothelialization of tissue-engineered heart valves
    Lichtenberg, A
    Cebotari, S
    Tudorache, I
    Sturz, G
    Winterhalter, M
    Hilfiker, A
    Haverich, A
    [J]. JOURNAL OF HEART VALVE DISEASE, 2006, 15 (02): : 287 - 293